Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/jamaoncol.2024.4757 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A simplified geriatric prognostic index to survival in older Asian patients with diffuse large B-Cell lymphoma treated with standard chemo-immunotherapy.
Ann Hematol
November 2024
Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore, 168583, Singapore.
While there are many proposed clinical prediction models for diffuse large B-cell lymphoma, like the International Prognostic Index (IPI), revised IPI and the National Comprehensive Cancer Network IPI, there is no widely used model for older patients. A recent study proposed a Geriatric Prognostic Index (GPI) validated in a Norwegian cohort, using independent predictors involving demographic, biochemical and functional parameters. This study aims to validate the GPI in an Asian cohort and simplify the GPI for ease of clinical application.
View Article and Find Full Text PDFReal-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer.
J Clin Med
October 2024
Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa 35254, Israel.
Article Synopsis
- Lung cancer is a serious disease with unique challenges, especially in patients diagnosed with resectable non-small cell lung cancer (NSCLC).
- A study from January 2022 to August 2023 involved 56 patients (mostly smokers and male) who received neoadjuvant chemo-immunotherapy before surgery, with 80% in stage III.
- Results showed 86% of patients had a positive response to treatment, and 61% had significant pathological improvements, highlighting the effectiveness of immune checkpoint inhibitors in treating NSCLC before surgery.
Chemoimmunotherapy in Older Adults With Non-Small Cell Lung Cancer-Reply.
JAMA Oncol
December 2024
Nihon Ika Daigaku Fuzoku Byoin, Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan.
Chemoimmunotherapy in Older Adults With Non-Small Cell Lung Cancer.
JAMA Oncol
December 2024
National Cancer Center/National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!